Amdocs Ltd (DOX) stock
Close on Nov 13, 2026Market cap $4.86BP/E 8.9Yield 4.60%
Earnings
Amdocs's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.
Quarterly results
Revenue and earnings per share from each of Amdocs's earnings releases, newest first
| Quarter | Reported | Revenue | YoY | EPS | Adj. EPS | Source |
|---|---|---|---|---|---|---|
| Q4 FY2025ended Sep 30, 2025 | Nov 12, 2025before the open | $1.15B | -9.0% | $0.88 | $1.83 | Release |
| Q3 FY2025ended Jun 30, 2025 | Aug 7, 2025after the close | $1.14B | -8.5% | $1.39 | $1.72 | Release |
| Q2 FY2025ended Mar 31, 2025 | May 8, 2025after the close | – | – | – | $1.78 | Release |
| Q1 FY2025ended Dec 31, 2024 | Feb 5, 2025during market hours | $1.11B | -10.8% | $1.33 | $1.66 | Release |
| Q4 FY2024ended Sep 30, 2024 | Nov 13, 2024during market hours | $1.26B | +1.7% | $0.76 | $1.70 | Release |
| Q3 FY2024ended Jun 30, 2024 | Aug 8, 2024after the close | $1.25B | +1.1% | $1.21 | $1.62 | Release |
| Q2 FY2024ended Mar 31, 2024 | May 9, 2024after the close | $1.25B | +1.9% | $1.01 | $1.56 | Release |
| Q1 FY2024ended Dec 31, 2023 | Feb 7, 2024during market hours | $1.25B | – | $1.26 | $1.56 | Release |
| Q4 FY2023ended Sep 30, 2023 | Nov 8, 2023during market hours | $1.24B | – | $0.86 | $1.42 | Release |
| Q3 FY2023ended Jun 30, 2023 | Aug 3, 2023during market hours | $1.24B | – | $1.32 | $1.57 | Release |
| Q2 FY2023ended Mar 31, 2023 | May 11, 2023during market hours | $1.22B | – | $1.23 | $1.47 | Release |
| Q1 FY2023ended Dec 31, 2022 | Feb 1, 2023during market hours | – | – | – | – | Release |
| Q4 FY2022ended Sep 30, 2022 | Nov 9, 2022during market hours | – | – | – | – | Release |
| Q3 FY2022ended Jun 30, 2022 | Aug 4, 2022after the close | – | – | – | – | Release |
| Q2 FY2022ended Mar 31, 2022 | May 12, 2022after the close | – | – | – | – | Release |
| Q4 FY2021ended Sep 30, 2021 | Nov 3, 2021after the close | – | – | – | – | Release |
| Q3 FY2021ended Jun 30, 2021 | Aug 5, 2021before the open | – | – | – | – | Release |
| Q2 FY2021ended Mar 31, 2021 | May 13, 2021during market hours | – | – | – | – | Release |
| Q1 FY2021ended Dec 31, 2020 | Feb 3, 2021during market hours | – | – | – | – | Release |
| Q4 FY2020ended Sep 30, 2020 | Nov 12, 2020during market hours | – | – | – | – | Release |
| Q2 FY2020ended Mar 31, 2020 | May 8, 2020during market hours | – | – | – | – | Release |
| Q1 FY2020ended Dec 31, 2019 | Feb 5, 2020during market hours | – | – | – | – | Release |
| Q3 FY2019ended Jun 30, 2019 | Aug 8, 2019after the close | – | – | – | – | Release |
| Q2 FY2019ended Mar 31, 2019 | May 15, 2019during market hours | – | – | – | – | Release |
| Q1 FY2019ended Dec 31, 2018 | Feb 6, 2019during market hours | – | – | – | – | Release |
| Q4 FY2018ended Sep 30, 2018 | Nov 9, 2018during market hours | – | – | – | – | Release |
Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.
Current guidance
Amdocs's latest outlook for periods it has not reported yet, compared with what it said before
| Metric | Period | Guidance | Before | Change | Given |
|---|---|---|---|---|---|
| Revenue Growth, as reportedGAAP | FY2025 | -10% – -9% | -11.6% – -8.4% | Narrowed | Aug 7, 2025 |
| Revenue Growth, Pro-forma (1) constant currency (2)non-GAAP | FY2025 | +2.4% – +3.4% | +1% – +4.5% | Narrowed | Aug 7, 2025 |
| Non-GAAP operating marginnon-GAAP | FY2025 | 21.1% – 21.7% | 21.1% – 21.7% | Reaffirmed | Aug 7, 2025 |
| GAAP Diluted earnings per shareGAAP | FY2025 | +31.5% – +33.5% | +27% – +34% | Narrowed | Aug 7, 2025 |
| Non-GAAP Diluted earnings per sharenon-GAAP | FY2025 | +8% – +9% | +6.5% – +10.5% | Narrowed | Aug 7, 2025 |
| Free Cash Flow (4)non-GAAP | FY2025 | $710.00M – $730.00M | $710.00M – $730.00M | Reaffirmed | Aug 7, 2025 |
| Non-GAAP effective tax ratenon-GAAP | FY2025 | 15% – 17% | 15% – 17% | Reaffirmed | Aug 7, 2025 |
| Revenue | Q1 FY2026 | $1.14B – $1.18B | – | New | Nov 12, 2025 |
| GAAP Diluted earnings per shareGAAP | Q1 FY2026 | $1.36 – $1.44 | – | New | Nov 12, 2025 |
| Non-GAAP Diluted earnings per sharenon-GAAP | Q1 FY2026 | $1.73 – $1.79 | – | New | Nov 12, 2025 |
| Revenue growth, as reportedGAAP | FY2026 | +1.7% – +5.7% | – | New | Nov 12, 2025 |
| Revenue growth, constant currencynon-GAAP | FY2026 | +1% – +5% | – | New | Nov 12, 2025 |
| Non-GAAP operating marginnon-GAAP | FY2026 | 21.3% – 21.9% | – | New | Nov 12, 2025 |
| GAAP diluted EPS growthGAAP | FY2026 | +13.5% – +20.5% | – | New | Nov 12, 2025 |
| Non-GAAP diluted EPS growthnon-GAAP | FY2026 | +4% – +8% | – | New | Nov 12, 2025 |
| Free cash flownon-GAAP | FY2026 | $710.00M – $730.00M | – | New | Nov 12, 2025 |
| Non-GAAP effective tax ratenon-GAAP | FY2026 | 16% – 19% | – | New | Nov 12, 2025 |
Guidance vs results
The last range Amdocs gave before each report, against the figure it then reported. Full years add up the four quarters.
| Period | Metric | Guidance | Actual | Result |
|---|---|---|---|---|
| Q4 FY2025 | EPS (GAAP) | $1.41 – $1.49 | $0.88 | Below range |
| Q4 FY2025 | Non-GAAP Diluted earnings per share | $1.79 – $1.85 | $1.83 | Within range |
| Q4 FY2025 | Revenue | $1.13B – $1.17B | $1.15B | Within range |
| Q2 FY2025 | Non-GAAP Diluted earnings per share | $1.67 – $1.73 | $1.78 | Above range |
| Q1 FY2025 | EPS (GAAP) | $1.20 – $1.29 | $1.33 | Above range |
| Q1 FY2025 | Non-GAAP Diluted earnings per share | $1.61 – $1.67 | $1.66 | Within range |
| Q1 FY2025 | Revenue | $1.10B – $1.14B | $1.11B | Within range |
| Q4 FY2024 | EPS (GAAP) | $1.34 – $1.42 | $0.76 | Below range |
| Q4 FY2024 | Non-GAAP Diluted earnings per share | $1.67 – $1.73 | $1.70 | Within range |
| Q4 FY2024 | Revenue | $1.24B – $1.28B | $1.26B | Within range |
| Q3 FY2024 | EPS (GAAP) | $1.24 – $1.32 | $1.21 | Below range |
| Q3 FY2024 | Non-GAAP Diluted earnings per share | $1.57 – $1.63 | $1.62 | Within range |
| Q3 FY2024 | Revenue | $1.24B – $1.28B | $1.25B | Within range |
| Q2 FY2024 | EPS (GAAP) | $1.21 – $1.29 | $1.01 | Below range |
| Q2 FY2024 | Non-GAAP Diluted earnings per share | $1.53 – $1.59 | $1.56 | Within range |
| Q2 FY2024 | Revenue | $1.23B – $1.27B | $1.25B | Within range |
| Q1 FY2024 | EPS (GAAP) | $1.18 – $1.26 | $1.26 | Within range |
| Q1 FY2024 | Non-GAAP diluted EPS | $1.53 – $1.59 | $1.56 | Within range |
| Q1 FY2024 | Revenue | $1.23B – $1.27B | $1.25B | Within range |
| Q4 FY2023 | EPS (GAAP) | $0.67 – $0.81 | $0.86 | Above range |
| Q4 FY2023 | Non-GAAP diluted EPS | $1.38 – $1.44 | $1.42 | Within range |
| Q4 FY2023 | Revenue | $1.22B – $1.26B | $1.24B | Within range |
| Q3 FY2023 | EPS (GAAP) | $1.16 – $1.26 | $1.32 | Above range |
| Q3 FY2023 | Non-GAAP diluted EPS | $1.45 – $1.51 | $1.57 | Above range |
| Q3 FY2023 | Revenue | $1.22B – $1.26B | $1.24B | Within range |
Guidance history
Every forecast Amdocs put in an earnings release, newest first
| Given | Metric | Period | Guidance | Change |
|---|---|---|---|---|
| Nov 12, 2025 | Non-GAAP Diluted earnings per share | Q1 FY2026 | $1.73 – $1.79 | New |
| Nov 12, 2025 | Non-GAAP diluted EPS growth | FY2026 | +4% – +8% | New |
| Nov 12, 2025 | GAAP diluted EPS growth | FY2026 | +13.5% – +20.5% | New |
| Nov 12, 2025 | GAAP Diluted earnings per share | Q1 FY2026 | $1.36 – $1.44 | New |
| Nov 12, 2025 | Free cash flow | FY2026 | $710.00M – $730.00M | New |
| Nov 12, 2025 | Non-GAAP operating margin | FY2026 | 21.3% – 21.9% | New |
| Nov 12, 2025 | Non-GAAP effective tax rate | FY2026 | 16% – 19% | New |
| Nov 12, 2025 | Revenue | Q1 FY2026 | $1.14B – $1.18B | New |
| Nov 12, 2025 | Revenue growth, constant currency | FY2026 | +1% – +5% | New |
| Nov 12, 2025 | Revenue growth, as reported | FY2026 | +1.7% – +5.7% | New |
| Aug 7, 2025 | Non-GAAP Diluted earnings per share | FY2025 | +8% – +9% | Narrowed |
| Aug 7, 2025 | Non-GAAP Diluted earnings per share | Q4 FY2025 | $1.79 – $1.85 | New |
| Aug 7, 2025 | GAAP Diluted earnings per share | FY2025 | +31.5% – +33.5% | Narrowed |
| Aug 7, 2025 | GAAP Diluted earnings per share | Q4 FY2025 | $1.41 – $1.49 | New |
| Aug 7, 2025 | Free Cash Flow (4) | FY2025 | $710.00M – $730.00M | Reaffirmed |
| Aug 7, 2025 | Non-GAAP operating margin | FY2025 | 21.1% – 21.7% | Reaffirmed |
| Aug 7, 2025 | Non-GAAP effective tax rate | FY2025 | 15% – 17% | Reaffirmed |
| Aug 7, 2025 | Revenue Growth, Pro-forma (1) constant currency (2) | FY2025 | +2.4% – +3.4% | Narrowed |
| Aug 7, 2025 | Revenue Growth, as reported | FY2025 | -10% – -9% | Narrowed |
| Aug 7, 2025 | Revenue | Q4 FY2025 | $1.13B – $1.17B | New |
| Feb 5, 2025 | Non-GAAP Diluted earnings per share | Q2 FY2025 | $1.67 – $1.73 | New |
| Feb 5, 2025 | Non-GAAP Diluted earnings per share | FY2025 | +6.5% – +10.5% | Reaffirmed |
| Feb 5, 2025 | GAAP Diluted earnings per share | FY2025 | +27% – +34% | Raised |
| Feb 5, 2025 | GAAP Diluted earnings per share | Q2 FY2025 | $1.30 – $1.38 | New |
| Feb 5, 2025 | Free Cash Flow (4) | FY2025 | $710.00M – $730.00M | Reaffirmed |
| Feb 5, 2025 | Non-GAAP operating margin | FY2025 | 21.1% – 21.7% | Reaffirmed |
| Feb 5, 2025 | Non-GAAP effective tax rate | FY2025 | 15% – 17% | Reaffirmed |
| Feb 5, 2025 | Revenue Growth, Pro-forma (1) constant currency (2) | FY2025 | +1% – +4.5% | Reaffirmed |
| Feb 5, 2025 | Revenue Growth, as reported | FY2025 | -11.6% – -8.4% | Lowered |
| Feb 5, 2025 | Revenue | Q2 FY2025 | $1.11B – $1.15B | New |
| Nov 13, 2024 | Non-GAAP Diluted earnings per share | Q1 FY2025 | $1.61 – $1.67 | New |
| Nov 13, 2024 | Non-GAAP diluted EPS growth | FY2025 | +6.5% – +10.5% | New |
| Nov 13, 2024 | GAAP diluted EPS growth | FY2025 | +25% – +33% | New |
| Nov 13, 2024 | GAAP Diluted earnings per share | Q1 FY2025 | $1.20 – $1.29 | New |
| Nov 13, 2024 | Free cash flow(5) | FY2025 | $710.00M – $730.00M | New |
| Nov 13, 2024 | Non-GAAP operating margin | FY2025 | 21.1% – 21.7% | New |
| Nov 13, 2024 | Non-GAAP effective tax rate | FY2025 | 15% – 17% | New |
| Nov 13, 2024 | Revenue | Q1 FY2025 | $1.10B – $1.14B | New |
| Nov 13, 2024 | Revenue growth, as reported | FY2025 | -10.9% – -7.7% | New |
| Nov 13, 2024 | Revenue growth, pro forma(2) constant currency(1) | FY2025 | +1% – +4.5% | New |
| Aug 8, 2024 | Non-GAAP Diluted earnings per share | Q4 FY2024 | $1.67 – $1.73 | New |
| Aug 8, 2024 | Non-GAAP Diluted EPS Growth | FY2024 | +8.5% – +9.5% | Narrowed |
| Aug 8, 2024 | GAAP Diluted EPS Growth | FY2024 | +7.4% – +9.2% | Narrowed |
| Aug 8, 2024 | GAAP Diluted earnings per share | Q4 FY2024 | $1.34 – $1.42 | New |
| Aug 8, 2024 | Free Cash Flow | FY2024 | $700.00M | Reaffirmed |
| Aug 8, 2024 | Non-GAAP operating margin | FY2024 | 18.1% – 18.7% | Reaffirmed |
| Aug 8, 2024 | Non-GAAP effective tax rate | FY2024 | 13% – 17% | Reaffirmed |
| Aug 8, 2024 | Revenue | Q4 FY2024 | $1.24B – $1.28B | New |
| Aug 8, 2024 | Revenue Growth in Constant Currency | FY2024 | +2.3% – +3.1% | Narrowed |
| Aug 8, 2024 | Revenue Growth, as reported | FY2024 | +1.9% – +2.7% | Narrowed |
| May 9, 2024 | Non-GAAP Diluted earnings per share | FY2024 | +7% – +11% | Lowered |
| May 9, 2024 | Non-GAAP Diluted earnings per share | Q3 FY2024 | $1.57 – $1.63 | New |
| May 9, 2024 | GAAP Diluted earnings per share | FY2024 | +7% – +13% | Lowered |
| May 9, 2024 | GAAP Diluted earnings per share | Q3 FY2024 | $1.24 – $1.32 | New |
| May 9, 2024 | Free Cash Flow (2) | FY2024 | $700.00M | Lowered |
| May 9, 2024 | Non-GAAP operating margin | FY2024 | 18.1% – 18.7% | Reaffirmed |
| May 9, 2024 | Non-GAAP effective tax rate | FY2024 | 13% – 17% | Reaffirmed |
| May 9, 2024 | Revenue Growth, constant currency (1) | FY2024 | +1.7% – +3.7% | Narrowed |
| May 9, 2024 | Revenue Growth, as reported | FY2024 | +1.6% – +3.6% | Narrowed |
| May 9, 2024 | Revenue | Q3 FY2024 | $1.24B – $1.28B | New |
| Feb 7, 2024 | Non-GAAP Diluted earnings per share | Q2 FY2024 | $1.53 – $1.59 | New |
| Feb 7, 2024 | Non-GAAP Diluted earnings per share | FY2024 | +8% – +12% | Reaffirmed |
| Feb 7, 2024 | GAAP Diluted earnings per share | FY2024 | +13% – +19.5% | Raised |
| Feb 7, 2024 | GAAP Diluted earnings per share | Q2 FY2024 | $1.21 – $1.29 | New |
| Feb 7, 2024 | Free Cash Flow | FY2024 | $750.00M | Reaffirmed |
| Feb 7, 2024 | Non-GAAP operating margin | FY2024 | 18.1% – 18.7% | Reaffirmed |
| Feb 7, 2024 | Non-GAAP effective tax rate | FY2024 | 13% – 17% | Reaffirmed |
| Feb 7, 2024 | Revenue Growth, constant currency | FY2024 | +1.2% – +5.2% | Reaffirmed |
| Feb 7, 2024 | Revenue Growth, as reported | FY2024 | +1.1% – +5.1% | Raised |
| Feb 7, 2024 | Revenue | Q2 FY2024 | $1.23B – $1.27B | New |
| Nov 7, 2023 | Non-GAAP diluted EPS | Q1 FY2024 | $1.53 – $1.59 | New |
| Nov 7, 2023 | Non-GAAP diluted EPS growth | FY2024 | +8% – +12% | New |
| Nov 7, 2023 | GAAP diluted EPS growth | FY2024 | +11% – +18% | New |
| Nov 7, 2023 | GAAP diluted EPS | Q1 FY2024 | $1.18 – $1.26 | New |
| Nov 7, 2023 | Free cash flow | FY2024 | $750.00M | New |
| Nov 7, 2023 | Non-GAAP operating margin | FY2024 | 18.1% – 18.7% | New |
| Nov 7, 2023 | Non-GAAP effective tax rate | FY2024 | 13% – 17% | New |
| Nov 7, 2023 | Revenue growth, constant currency | FY2024 | +1.2% – +5.2% | New |
| Nov 7, 2023 | Revenue | Q1 FY2024 | $1.23B – $1.27B | New |
| Nov 7, 2023 | Revenue growth, as reported | FY2024 | +1% – +5% | New |
| Aug 2, 2023 | Non-GAAP diluted EPS | Q4 FY2023 | $1.38 – $1.44 | New |
| Aug 2, 2023 | Non-GAAP diluted EPS growth | FY2023 | +11% – +12% | Narrowed |
| Aug 2, 2023 | GAAP diluted EPS | Q4 FY2023 | $0.67 – $0.81 | New |
| Aug 2, 2023 | GAAP diluted EPS growth | FY2023 | -3% – 0% | Lowered |
| Aug 2, 2023 | Free cash flow (1) | FY2023 | $700.00M | Reaffirmed |
| Aug 2, 2023 | Non-GAAP effective tax rate | FY2023 | 13% – 17% | Reaffirmed |
| Aug 2, 2023 | Revenue growth, constant currency (2) | FY2023 | +7.2% – +8% | Narrowed |
| Aug 2, 2023 | Revenue | Q4 FY2023 | $1.22B – $1.26B | New |
| Aug 2, 2023 | Revenue growth, as reported | FY2023 | +6.3% – +7.1% | Narrowed |
| May 10, 2023 | Non-GAAP diluted EPS growth | FY2023 | +9% – +13% | New |
| May 10, 2023 | Non-GAAP diluted EPS | Q3 FY2023 | $1.45 – $1.51 | New |
| May 10, 2023 | GAAP diluted EPS growth | FY2023 | +3% – +10% | New |
| May 10, 2023 | GAAP diluted EPS | Q3 FY2023 | $1.16 – $1.26 | New |
| May 10, 2023 | Free cash flow | FY2023 | $700.00M | New |
| May 10, 2023 | Non-GAAP effective tax rate | FY2023 | 13% – 17% | New |
| May 10, 2023 | Revenue | Q3 FY2023 | $1.22B – $1.26B | New |
| May 10, 2023 | Revenue growth, constant currency | FY2023 | +7% – +9% | New |
| May 10, 2023 | Revenue growth, as reported | FY2023 | +6% – +8% | New |
Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.
Press releases
Releases Amdocs filed with the SEC as exhibits to Form 8-K or 6-K
- 6-K
- 6-K
- 6-K
- 6-K
- 6-K
- 6-K
- 6-K
- 6-K
- 6-K
- 6-K
- 6-K
- 6-K
- 6-K
- 6-K
- 6-K
See a number that looks wrong?